Inactive Instrument

Press Releases LA JOLLA PHARM Other OTC

Equities

End-of-day quote Other OTC Other stock markets
- ^USD	-

2022	La Jolla Pharmaceutical Announces Management Changes	CI
2022	La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	22-08-24	PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	22-08-24	PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	22-08-24	PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	22-08-24	PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	22-08-24	PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	22-08-24	PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4	22-08-24	PU
La Jolla Pharmaceutical : Termination of a Material Definitive Agreement - Form 8-K	22-08-22	PU
LA JOLLA PHARMACEUTICAL CO : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-08-22	AQ
LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-15	AQ
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders	22-07-28	BU
Equity Alert - The M&A Class Action Firm Announces the Investigation of La Jolla Pharmaceutical Co. - LJPC	22-07-16	PR
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership (Form 4)	22-07-12	PU
SHAREHOLDER ALERT: Weiss Law Investigates La Jolla Pharmaceutical Company	22-07-11	PR
LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC	22-07-11	BU
Twitter, Las Vegas Sands fall; Mullen, La Jolla rise	22-07-11	AQ
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders	22-07-11	BU
La Jolla Pharmaceutical : Innoviva to Acquire La Jolla Pharmaceutical Company - Form 8-K	22-07-11	PU
LA JOLLA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	22-07-11	AQ
Innoviva to Acquire La Jolla Pharmaceutical Company	22-07-11	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases LA JOLLA PHARM Other OTC

Equities

Press Releases

Filters